Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | ALOX15B | O15296 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imidazole SCHEMBL27886809 | 0.85 | ALDH1A1 (0.36) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL9441512 | 0.82 | CYP3A4 (0.42) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL28763247 | 0.81 | CYP3A4 (0.42) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL2085218 | 0.81 | ATM (0.48) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL8830211 | 0.81 | CYP3A4 (0.43) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL9441377 | 0.78 | CYP3A4 (0.48) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL28005734 | 0.74 | NPC1 (0.43) | L3MBTL1SMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL15758610 | 0.74 | PLA2G4A (0.47) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL15758608 | 0.74 | PLA2G4A (0.47) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL27376195 | 0.74 | CYP3A4 (0.46) | CYP3A4L3MBTL1CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102863387-B | Novel synthetic method for imidazole onium salts | UNIV SICHUAN | 2015-07-08 | — | — | CN | claimed |
| CN-102867989-A | Non-aqueous electrolyte ionic liquid additive for improving high-temperature performance of battery | INST PROCESS ENG CAS | 2013-01-09 | — | — | CN | claimed |
| CN-102820485-A | Ionic liquid additive capable of promoting film formation of graphite cathode of lithium ion battery | INST PROCESS ENG CAS | 2012-12-12 | — | — | CN | claimed |
| CN-102810690-A | High-voltage ionic liquid electrolyte for lithium ion battery and preparation method of high-voltage ionic liquid electrolyte | INST PROCESS ENG CAS | 2012-12-05 | — | — | CN | claimed |
| CN-101345325-A | Lithium ion battery electrolytic solution for promoting graphite cathode film formation and lithium ion battery made by the same | ZHANGJIAGANG GUOTAI HUARONG NE (CN) | 2009-01-14 | — | — | CN | claimed |
| CN-113517470-A | High-nickel high-voltage ternary lithium ion battery non-aqueous electrolyte and lithium ion battery | 杉杉新材料（衢州）有限公司 | 2021-10-19 | — | — | CN | disclosed |
| CN-113394450-A | Lithium cobaltate high-voltage lithium ion battery non-aqueous electrolyte and lithium ion battery | 杉杉新材料（衢州）有限公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-102867989-A | Non-aqueous electrolyte ionic liquid additive for improving high-temperature performance of battery | INST PROCESS ENG CAS | 2013-01-09 | — | — | CN | disclosed |
| CN-102820485-A | Ionic liquid additive capable of promoting film formation of graphite cathode of lithium ion battery | INST PROCESS ENG CAS | 2012-12-12 | — | — | CN | disclosed |
| CN-102810690-A | High-voltage ionic liquid electrolyte for lithium ion battery and preparation method of high-voltage ionic liquid electrolyte | INST PROCESS ENG CAS | 2012-12-05 | — | — | CN | disclosed |
| US-7825149-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2010-11-02 | — | — | US | disclosed |
| US-20090312326-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2009-12-17 | — | — | US | disclosed |
| US-7547718-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-06-16 | — | — | US | disclosed |
| US-7544706-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-06-09 | — | — | US | disclosed |
| CN-101345325-A | Lithium ion battery electrolytic solution for promoting graphite cathode film formation and lithium ion battery made by the same | ZHANGJIAGANG GUOTAI HUARONG NE (CN) | 2009-01-14 | — | — | CN | disclosed |
| US-20080125473-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2008-05-29 | — | — | US | disclosed |
| US-20080119536-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125473-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | CYP3A4 3/4885L3MBTL1 1548/4885CYP1A2 12/4885 |
| US-20090312326-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | CYP3A4 3/4885L3MBTL1 1548/4885CYP1A2 12/4885 |
| US-20080119536-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | CYP3A4 3/4885L3MBTL1 1548/4885CYP1A2 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.